How many people have tested positive after the second dose of the Covid vaccine? Government shares data

The Indian government on Tuesday shared data on the number of people who tested positive for the novel coronavirus after receiving the second dose of Covid-19 vaccines.

According to the data, around 0.04% of people tested positive after the second dose of Covaxin and 0.03% after the second dose of Covishield, the Department of Health said in the press.

India has currently granted emergency use authorization for three candidate vaccines: locally manufactured vaccines (Serum Institute of India and Bharat Biotech) and a third vaccine (Sputnik) which, although currently being manufactured in India foreigner, will eventually be made in India.

Among those under 10 years of age, 4.03 cases of COVID-19 pc were reported in the first wave, while 2.97 pc cases were recorded in the second wave, he added. In the 10-20 year age group, 8.07 pc of COVID-19 cases were reported in the first wave, while 8.50 pc of cases were recorded in the second wave. In the 20-30 age group, 20.41 cases of COVID-19 pc were reported in the first wave, while 19.35 pc cases were recorded in the second wave, while among those aged 30 and over more, 67.5 pc cases of COVID-19 were reported in the first wave, while 69.18 pc cases were recorded in the second wave: Govt, the health ministry said.

Reviewing the Covid-19 situation in the country, Health Secretary Rajesh Bhushan said: “There are 21.57,000 active cases in India currently, double the maximum number of active COVID-19 cases last year. More than 13 million people have been vaccinated in the country to date, including 30 lakh doses given in the past 24 hours. “

On Monday, the Center also announced a “liberalized and accelerated” phase 3 COVID-19 vaccination strategy from May 1 to speed up the coronavirus vaccination campaign in the country.

Anyone over the age of 18 may be eligible for the Covid-19 vaccine, the government said.

To subscribe to Mint newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

Source